Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
City of Hope Medical Center
City of Hope Medical Center
National Cancer Institute (NCI)
Kyowa Kirin Co., Ltd.
Eli Lilly and Company
Bristol-Myers Squibb
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
University of Washington